Small Molecules
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,409
NCT01146925
Deferiprone for the Prevention of Contrast-Induced Acute Kidney Injury
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2010
Completion: Jun 30, 2011
NCT01391520
Efficacy and Safety of Deferiprone in Patients With Chronic Kidney Disease Undergoing a Cardiac Catheterization and Receiving Contrast Agent
Phase: Phase 3
Start: Jan 31, 2012
Completion: Jun 30, 2013
NCT02651428
Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
Start: Dec 31, 2015
Completion: Oct 31, 2018
NCT05117866
Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study
Phase: N/A
Start: Sep 15, 2020
Completion: Dec 31, 2025
NCT06822426
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
Start: May 14, 2025
Completion: Jan 31, 2027
NCT06714864
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
Phase: Phase 4
Start: Jul 8, 2025
Completion: Mar 31, 2026
Loading map...